Scientific Online Resource System

Varna Medical Forum

Selenium deficit and metabolism

Vania Mihova Pepelyasheva, Dobrina Pepeliasheva

Abstract

Selenium is an essential trace element for the human body. As such, its deficiency affects different metabolic processes and is associated with various disease states. The ingestion of selenium in the form of selenocysteine and selenomethionine considerably affects the biochemical profile of thyroid gland complaints as the level of effectiveness is highly influenced by the therapeutic scheme. At the same time the toxicity of the element, the selenium stress felt by prokaryotic and eukaryotic microbial cells at high doses of selenium and its accumulation during prolonged use should be taken into account.


Keywords

селен, метаболизъм,селенов дефицит, селеноза, заболявания, селенов стрес.

Full Text


References

Гавраилова Д., Селен – биологична роля за здравето, Наука Диететика, 1-2, 2013, 5-9.

Гавраилова Д., Мястото на селена в лечението на тиреоидните заболявания, български медицински журнал, VII, 2013, №

Стоянов Ст., Тежки метали в околната среда и хранителните продукти, токсично увреждане на човека, клинична картина, лечение и профилактика, Изд. „Пенсофт”, София, 1999, 229-239.

Ершов Ю., Пременева Т., Механизмы токсического действия неорганических соединений, Изд. „Медицина”, Москва, 1989, 247 – 251.

Arner E. S., . Holmgner, Physiological Function of Thioredoxin and Thioredoxin reductase, Eur J. Biohem, 2000, 267, 6102-6109.

Conrat M., Jakupoglu C., Moreno S. G., Lippl S., Banjac A. et al. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development and heart function, Mol. Cell. Biol, 2004, № 24, 9414-9423.

Derumeaux H., Valeix P., Castetbon K., Bensimon M., Boutron-Ruault M. C., Arnaut J. et al. Association of selenium with thyroid volume and echostructure in 35 to 60 year old French adults, Eur. J. Endocrinol, 148, 2003, 309-315.

Duntas L. H., E. Mantzou et D. A. Koutras. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. – Eur. J. Endocrinol, 148, 2003, 389-393.

Garbisu C., Karlson D., Adamkievicz M., Yee B.C., Wong H.Y., Resto E. et al, Mobilization of selenite by Ralstonia. Morphologocal and biochemical responses of Bacillus subtilis to selenite strees, Biofactors, 10, (1999) 311-319.

Нonnghausen L., Hatfild L., Gladishev V., Carlson B., Morgan F., Mousni K. et al, Selective Removal of the Selenocysteine tRNA Ser Sec Gene (Trap) in Mouse Mammary Epithelium, Mol. Cell., Biol., 23, № 5, 2003, 1477-1488.

Jakopoglu C., Pezemeck G. K., Schneider M., Moreno S. G., Mayr N., Hatzopoulos A. K. et al., Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development, Mol Cell Biol, 2005, 25, 1980-1988.

Karanikas G., Schuetz M., Kontur S., Duan H., Kommata S., Schoen R. et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis, Thyroid, 18,2008, 7 – 12.

Mazokopakis E. E, Papadakis J. A., Papadomanolaki M. G., Batistakis A. G., Giannakopoulos T., G., Protopapadakis E. E. et al, Effects of 12 months treatment with L-selenomethionine on serum anti-TRO Levels in Patients with Hashimoto’s thyroiditis, Thyroid, 17, 2007, № 7, 609 – 612.

Rasmussen L. B., Schomburg L., Köhrle J., Pedersen I. B., Hollenbach B., Hög A. et al. Selenium status, thyroid volume and multiple nodule formation in an area with mild iodine deficiency, Eur. J. Endocrinol, 164, 2011, 585-590.

Roux M., Sarret G., Pignot – Paintrand I., Fontecave M., Coves J., Mobilization of Selenite by Ralstonia metallidurans CH 34, Applied and Environmental Microbiology, 67, № 2, 2001, 769-773.

Turker O., Kumanlioglu K., Karapolat I., Dogan I., Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses, J. Endocrinol, 190, 2006,151-156.

Schomburg L., Köhrle J., On the Importance of Selenium and Iodine Metabolism for Thyroid Hormone Biosynthesis, Mol. Nutr Food Res, 2008, № 52, 1235-1246.


Refbacks

Font Size


|